The quantity of β‐carotene (BC) accumulated in colonic polyps and colonic cancererous tissue in humans in situ was determined relative to the quantity accumulated in normal colon and rectal tissue. Serum concentration of BC, retinol, and α‐tocopherol and tissue BC concentration were determined by high‐performance liquid chromatography in samples obtained before and after oral supplementation with BC (30 mg/day). The serum BC and retinol concentrations significantly increased in response to supplementation in control, polyp, and cancer patients, but there was no change in serum α‐tocopherol concentration. The BC concentration in tissue (colon, rectum, and tumor) of cancer patients was significantly less than that in tissue samples from control and polyp patients. Relative to baseline values, BC accumulated to a significant extent in tissues from all patients, including polyp and tumor tissue, during supplementation. The results indicate that BC does accumulate in colonic neoplastic tissue in humans and may potentially be utilized to augment cytotoxicity of chemotherapeutics or to prevent malignant transformation of cells.
13 January 2015 in Langenbeck's Archives of Surgery
Objectives: (1) To compare tissue and plasma carotenoids status of healthy subjects and subjects with pre-cancer and cancer lesions; (2) to evaluate the effect of β-carotene supplementation on the concentrations of other carotenoids in tissue (luteine+zeaxanthin, cryptoxanthin, lycopene, α-carotene) and in plasma and also retinol and α-tocopherol levels. Design: Eighteen subjects were divided into three groups on the basis of colonoscopy and histological analytical findings: four healthy subjects (control group A); seven subjects affected by adenomatous polyps (group B with pre-cancer lesions); seven subjects suffering from colonic cancer (group C). Blood and colonic biopsy samples were taken (of colon and rectal mucosa) before and after β-carotene supplementation in all subjects. Groups A and B received a daily dose of β-carotene (30 mg/die) for 43 d. Group C’s supplementation was terminated at the time which was performed, usually within 15 d. The tissue and plasma concentration of carotenoids, retinol and α-tocopherol were determined by high-performance liquid chromatography. Results: The tissue concentrations of each carotenoid were similar in all the intestinal sites examined as regards groups A and B, although there was a high degree of intra individual variability within each group. Only β-carotene made significant increases (P<0.001) after supplementation. The subjects with cancer show tissue levels for each carotenoid lower than those of healthy subjects or subjects with polypous. The plasma levels of α-tocopherol did not change after supplementation while significant increases were noted of retinol, α-carotene (P<0.01) and of β-carotene (P<0.001). Conclusions: The patients with colonic cancer seemed to undergo a significant reduction in their antioxidant reserves with respect to the normal subjects and or polyps. We can confirm that oral B-carotene supplementation induces also an increase in plasma α-carotene in all groups. Sponsorship: This work was supported by the National Research Council of Italy, Special Projects RAISA, Sub project 4, Grant 95.00.206.PF38.